Gene Therapy for Sickle Cell Disease, beta-Thalassemia Enters Regulatory Reviews. Larkin HD. JAMA 2022;328:1798.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Larkin HD. Gene Therapy for Sickle Cell Disease, beta-Thalassemia Enters Regulatory Reviews. JAMA 2022;328:1798.
PMID: 36346425